Margarita Papatheodoridi
Margarita Papatheodoridi is an expert in Hepatology at Laiko General Hospital of Athens (Greece). Margarita Papatheodoridi has authored 106 publications, the most recent in 2026. SLR score: 350 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Gastroenterology - Infectiology - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2022 - 2026
Number : 106
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management. PMID 42358056 — research design, disease management, hepatitis d, hepatitis delta virus, liver, interferon-alpha, diagnosis, therapeutics, antiviral agents, hepatitis | Liver Int | 2026 | 0 |
| Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort. PMID 42409322 — liver diseases, tenofovir, carcinoma, hepatocellular, incidence, neoplasms, hepatitis, chronic, liver, therapeutics, hepatitis b, hepatitis b, chronic, hepatitis | J Hepatol Top journal | 2026 | 3 |
| HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis D. PMID 42322023 — hepatitis d, hepatitis d, chronic, prescriptions, hepatitis, chronic, therapeutics, hepatitis, viral, human, hepatitis | J Viral Hepat | 2026 | 1 |
| Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohort. PMID 42162913 — hepatitis d, fibrosis, hepatitis d, chronic, hepatitis delta virus, hepatitis, chronic, liver, therapeutics, antiviral agents, infections, hepatitis, liver stiffness | JHEP Rep | 2026 | 0 |
| Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B - follow-up from the RETRACT-B cohort. PMID 41921700 — liver diseases, hepatitis, chronic, liver, retreatment, therapeutics, history, hepatitis b, hepatitis b, chronic, hepatitis | J Hepatol Top journal | 2026 | 0 |
LeadR Networks
Main global connection map